Sfee press release_disclosure_code_20141009_2Market iT
EFPIA Member Association SFEE (The Hellenic Association of Pharmaceutical Companies) last week introduced a new code of industry self-regulation, in line with the EFPIA Disclosure Code
Understanding the health data future - Deloitte Healthconnect, co-hosted by D...DayOne
In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: “Understanding the health data future – Deloitte Healthconnect, co-hosted by DayOne”
As leaders we understand that our job is to possibly idolize and c.docxfestockton
As leaders we understand that our job is to possibly idolize and carry out the impossible. Healthcare managers primary role is to manage and maintain stabilization. One of the main issues that effects healthcare is intelligence taking over an organization in a setting where elderly people can barely function coherently alone. Quest Diagnostics has switched over to electronically checking in on a kiosk system. MyQuest benefits a patient to receive their results on a portal, without going through the hassle of contacting your doctor or avoiding anxiety throughout the wait for a call back. Is this change saving a hassle or enhancing complications and trouble in an organization?
Change can be hard for some and easy for others. To the healthcare professional manager a change in a structured system may benefit the pace and results of outcomes at this organization. To the patient it may be an additional loop hole in the obstacle course they are not in favor of. The problem initiates when there’s order put in place to carry out new solutions effectively and there’s a complaint and the manager has to see how to satisfy this one customer out of a million because this too can be the rise or fall of an appointment. Managers should stand on what they believe is a better system that works for the majority and not bend it for any reason. Once there’s a tweak in the system it opens up a hole for everyone to think rules will be bent if there’s a complaint. We should question our thinking and communicate effectively with all other leadership to create the most effective system to please as much of the patients as possible. We can not please every human and doing cover ups or quick fixes creates a catastrophe.
Most doctors that have been practicing for years are used to coding manually and paper charts. Recently in the past two years all healthcare settings are forced to switch to icd coding, a new set of codes that are put in place to take the old ones that had been used for years out. This helps the specifications of the patient condition to easily communicate with the patients insurance and lessens the use of multiple codes. This also alters the doctors practice when they are still using paper orders and charts and haven’t learned the codes correctly so are causing patients to be billed by insurance.
When critically analyzing the solution to this problem we should use the problem-solving skills of asking the 5 whys. In a fast past setting we usually like to immediately fix the problem in the area or satisfy the majority. This can result to quick fixes which is like only placing a band aid over a bullet wound. Longterm this result can be detrimental to the organization. Quick fixes should be avoided as much as possible by healthcare management or anyone in leadership.
· Stephens, J. H., & Ledlow, G. R. (2010). Real healthcare reform: Focus on primary care access. Hospital Topics, 88(4), 98–106.
· Cliff, B. (2012). Excellence in patient satis ...
Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Sfee press release_disclosure_code_20141009_2Market iT
EFPIA Member Association SFEE (The Hellenic Association of Pharmaceutical Companies) last week introduced a new code of industry self-regulation, in line with the EFPIA Disclosure Code
Understanding the health data future - Deloitte Healthconnect, co-hosted by D...DayOne
In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: “Understanding the health data future – Deloitte Healthconnect, co-hosted by DayOne”
As leaders we understand that our job is to possibly idolize and c.docxfestockton
As leaders we understand that our job is to possibly idolize and carry out the impossible. Healthcare managers primary role is to manage and maintain stabilization. One of the main issues that effects healthcare is intelligence taking over an organization in a setting where elderly people can barely function coherently alone. Quest Diagnostics has switched over to electronically checking in on a kiosk system. MyQuest benefits a patient to receive their results on a portal, without going through the hassle of contacting your doctor or avoiding anxiety throughout the wait for a call back. Is this change saving a hassle or enhancing complications and trouble in an organization?
Change can be hard for some and easy for others. To the healthcare professional manager a change in a structured system may benefit the pace and results of outcomes at this organization. To the patient it may be an additional loop hole in the obstacle course they are not in favor of. The problem initiates when there’s order put in place to carry out new solutions effectively and there’s a complaint and the manager has to see how to satisfy this one customer out of a million because this too can be the rise or fall of an appointment. Managers should stand on what they believe is a better system that works for the majority and not bend it for any reason. Once there’s a tweak in the system it opens up a hole for everyone to think rules will be bent if there’s a complaint. We should question our thinking and communicate effectively with all other leadership to create the most effective system to please as much of the patients as possible. We can not please every human and doing cover ups or quick fixes creates a catastrophe.
Most doctors that have been practicing for years are used to coding manually and paper charts. Recently in the past two years all healthcare settings are forced to switch to icd coding, a new set of codes that are put in place to take the old ones that had been used for years out. This helps the specifications of the patient condition to easily communicate with the patients insurance and lessens the use of multiple codes. This also alters the doctors practice when they are still using paper orders and charts and haven’t learned the codes correctly so are causing patients to be billed by insurance.
When critically analyzing the solution to this problem we should use the problem-solving skills of asking the 5 whys. In a fast past setting we usually like to immediately fix the problem in the area or satisfy the majority. This can result to quick fixes which is like only placing a band aid over a bullet wound. Longterm this result can be detrimental to the organization. Quick fixes should be avoided as much as possible by healthcare management or anyone in leadership.
· Stephens, J. H., & Ledlow, G. R. (2010). Real healthcare reform: Focus on primary care access. Hospital Topics, 88(4), 98–106.
· Cliff, B. (2012). Excellence in patient satis ...
Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Abstract:
Currently, there is a convergence of three key factors in the global landscape that creates an opportunity for the research community to make fundamental contributions to improving the quality of life of every single citizen. Conversely, failure to recognize and act on this phenomenon may have disastrous effects on multiple levels. The first factor is the unprecedented focus and willingness to invest in the healthcare industry. The second factor is the fact that the prime directive of the healthcare sector, i.e. nothing interferes with the delivery of care, has ramifications on every aspect of information technology used in this domain. The final factor is the recognition that patient empowerment and buy-in will be critical for the advance of health information technology. These factors highlight the fact that there are inherent assumptions in the existing access models that render them ineffective and not applicable for long term use in the healthcare field.
This talk will highlight all these issues and challenge the research community to delve more the industry-specific constraints that require further innovation in the space; possibly necessitating a re-examination of the core assumptions in the field.
Bio:
Tyrone Grandison is currently the Program Manager for Core Healthcare Services in the Healthcare Transformation group of the IBM Services Research organization (Hawthorne, New York). His immediate interests are in developing innovative solutions for ensuring patient privacy protection and for integrating information from multiple sources to get more complete views of patients to enable better decision making. Prior to this, Tyrone led the Intelligent Information Systems (Quest) team in the Computer Science department at the IBM Almaden Research Center (San Jose, California). The team pioneered research in Relational Database Privacy, Disclosure-Compliant Query Processing for RFID and Mobile Data Networks, Security Exception Handling in Healthcare Information Systems and Large Scale Text Analysis of Online Data. Tyrone is a Distinguished Engineer of the Association of Computing Machinery (ACM), Senior Member of the Institute of Electrical and Electronics Engineers (IEEE) and has been further recognized by the IEEE (2010 Technical Achievement Award), the National Society of Black Engineers (i.e. Pioneer of the Year 2009) and the Black Engineer of the Year Award Board (i.e. Modern Day Technology Leader 2009, Minority in Science Trailblazer 2010). Tyrone received his B.Sc. and M.Sc. degrees from the University of the West Indies, Jamaica in 1997 and 1998, respectively, and a Ph.D. degree from the Imperial College of Science, Technology and Medicine in the United Kingdom.
Presented: June 9, 2010
A Final Report Submitted in Partial Fulfillment of the Requirements of 1210327 Thai Aviation Business in Global Aviation Industry Course,
Mae Fah Luang University,
First Semester, 2014
Following the unprecedented ramifications of the coronavirus pandemic and subsequent uncertainty over both the safety and viability of holding physical events, Global Trade Review is delighted to announce that GTR Asia 2020, the world's largest trade finance gathering, will this year be taking place virtually, on September 8-11.
This exciting new initiative, combining a mixture of live-streamed and pre-recorded content and unrivalled networking via GTR's dedicated virtual event platform, will offer the chance to hear the latest developments from experts on the many challenges faced across the industry, as well as the chance to connect with speakers, sponsors and attendees alike across the 4 days.
Horizon 2035: Developing a long-term strategic vision for the health, social ...C4WI
The CfWI presented three papers at the Business Systems Laboratory International Symposia on 21 January. This presentation focuses on work being done as part of the CfWI's flagship Horizon 2035 programme.
Similar to Global MedTech Compliance Conference 2015 (20)
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
1. DRAFT AGENDA
1
19-21 May 2015
Athens Hilton
Athens, Greece
2015 Global MedTech Compliance Conference, Athens
19-21 May
DAY TIME PROGRAM
TUESDAY
19 May
08.00 – 17.00 Global Medical Technology Alliance (GMTA)
(Parallel session) - Members only
(Thalia 1)
10.00 – 17.00 Greek Distributor Training (SEIV) – Open session requiring separate
registration (in Greek) (Parallel session)
(Thalia 2&3)
10.00 – 12.30 AdvaMed Device and Diagnostics Compliance Group (DDCG)
(Parallel session) - Members only
(Hesperides)
10.00 – 12.30 MedTech Europe Compliance Network (CN)
(Parallel session)- Members only
(Santorini)
12.30– 13.45 Joint DDCG-CN-GMTA-SEIV Lunch
(Terpsichore D)
13.45 – 17.00 Joint DDCG-CN Session - Members only
(Santorini)
18.00 – 19.30 PwC Compliance Achievement Award & Networking Cocktail
(Galaxy Room)
DAY TIME PROGRAM
WEDNESDAY
20 MAY
07.30 Registration and welcome coffee
(Terpischore Pre Function Room)
09.00 – 09.30 Opening session (Terpsichore AB)
‐ Associations CEOs Panel i.e. Steve Ubl - AdvaMed, Serge
Bernasconi - MedTech Europe & Paul Arnaoutis – SEIV
(confirmed)
09.30 – 9.50 Welcome address
09.50 – 10.45 Plenary session: Anti-corruption, business ethics, innovation &
partnerships: A governmental perspective ( Terpsichore AB)
‐ Candice Welsch, Chief, Implementation Support Section
Corruption and Economic Crime Branch
United Nations Office on Drugs and Crime (confirmed)
Moderator: tbc
Panel Description: Discussion with international organisations and
governmental officials on the value of public-private partnerships to
fight corruption, including views on anti-corruption best practices
2. DRAFT AGENDA
2
19-21 May 2015
Athens Hilton
Athens, Greece
and current trends.
10.45 – 11.15 Networking break
(Convention Level and the Erato Terrace)
11.15 – 12.30 Parallel session 1: Expert panel on distributor-related issues: “How
Would Experts Manage this Distributor Compliance Scenario
(Thalia 123)
‐ Bronwen Taylor, VP, Compliance & Risk Management,
Stryker Corporation
‐
Moderator: tbc
Panel Description: Senior compliance officers will be invited to
discuss and comment on a hypothetical roll-out scenario relating to
the topic of distributors.
11.15 – 12.30 Parallel session 2: Did Sunshine bring transparency? (Hesperides)
‐ Laure Le Calvé, Avocat associée, LCH (confirmed)
‐ EFPIA (confirmed)
‐ Ann S. Brandt, Partner, HealthCare Appraisers, Inc.
(confirmed)
Moderator: Frederick Robinson, Partner, Norton Rose Fulbright
(confirmed)
Panel Description: Discussion on the latest transparency
developments, and how these initiatives can meet the pre-
determined objectives, and more generally provide value.
11.15 – 12.30 Parallel session 3: Where is the compliance officer profession
headed? (Santorini)
‐ Arthur Muratyan, Secretary General, ETHICS (confirmed)
‐ Kathleen M. Boozang, Associate Dean for Academic
Advancement & Professor of Law, Seton Hall University
School of Law (confirmed)
Moderator: UL (confirmed)
Description: Discussion on the role and the profession of the
Healthcare Compliance Officer. This includes considerations such as
the current and future trends of this professions, its place within the
company, as well as the existing training programs and educational
pathways for Ethics and Compliance practitioners.
3. DRAFT AGENDA
3
19-21 May 2015
Athens Hilton
Athens, Greece
11.15 – 12.30 Parallel session 4: Industry consolidation: What does it mean for
compliance? (Thalia 4)
Moderator: tbc
Description: As the MedTech industry is consolidating at an
unprecedented speed, this session will discuss, what does it mean
practically for the compliance function and what are the pitfalls in
deal-making that should be avoid (e.g. before-during-after, re-
consolidation, rebates, competition law).
12.30 – 13.45 Networking Lunch
(Terpsichore D)
13.45 – 15.15 "Coffee Talk": Get Your National Update, and Discuss the Latest
Developments with Your Peers (requires participant selection at the
time of registration, limited to 10 per table) (Thalia 1 2 and 3)
Moderator: Mike Koon, Partner, Norton Rose Fulbright (confirmed)
‐ Brazil:
‐ Colombia:
‐ China:
‐ Denmark:
‐ Greece:
‐ Middle East region:
‐ India:
‐ Russia: David Smith, Executive Director, Fraud Investigation
& Dispute Services, EY (Russia) (confirmed)
‐ Poland & Eastern Europe:
‐ France: Laure Le Calvé, Avocat associée, LCH (confirmed)
‐ Spain & Southern Europe
‐ USA
‐ Australia/Japan
‐ Europe:
‐ International Fair-Market Value: Ann S. Brandt, Partner,
HealthCare Appraisers, Inc. (confirmed)
15.15 – 15.45 Networking break
(Convention Level and the Erato Terrace)
15.45 – 16.00 “Public Perception and Media”? Views on MedTech business ethics
(Terpsichore AB)
4. DRAFT AGENDA
4
19-21 May 2015
Athens Hilton
Athens, Greece
16.00 – 17.00 Plenary session: CEO Roundtable on Global Compliance
(Terpsichore AB)
‐ Stefan Wolf, EDMA Board member & CEO for the HHS
Business Unit, Siemens Healthcare Diagnostics (confirmed)
‐ Jeff Dunn, President and CEO, SI-Bone (confirmed)
‐ Mike Mussallem, Chairman & CEO, Edwards Lifesciences
Corporation (confirmed)
Moderator: Ted Acosta, Partner, Ernst & Young (invited)
Description: In this session, business leaders will provide their
thoughts on what the industry is going through right now in the field
of ethics and compliance (e.g. transparency, consolidation, phasing
out of direct sponsorship). This session also provide the "tone at the
top", illustrating the support of business leaders to the legal and
compliance community, commenting on the role of trade
associations in this field of ethics and compliance as well as
providing the opportunity to explain what they would like to see in
terms of compliance in their company.
18.30 – 20.00 Cocktail Reception (TBD)
THURSDAY
21 May
07.00 Registration
(Terpischore Pre Function Room)
08.45 – 10.00 Plenary session: Direct sponsorship of HCPs to third-party
organized conferences: Global trends and challenges
(Terpsichore AB)
Moderator: PwC (confirmed)
Description: Direct sponsorship, i.e. the provision of financial
support to healthcare professionals (“HCPs”) by healthcare
companies to attend passively third-party medical education
conferences has been a topic of significant importance. Direct
sponsorship is not allowed in certain countries and it is a big topic in
all the other countries, some of them taking different measures to
limit or prohibit various forms of sponsorship. In light of this fast-
changing environment, the discussion will examine the subject in
detail and to try to identify the challenges ahead, when direct
sponsorship will not be possible anymore.
5. DRAFT AGENDA
5
19-21 May 2015
Athens Hilton
Athens, Greece
10.00-11.00 Plenary session: Exchange of best practices: Meeting the challenges
of the transition towards an “indirect-only-sponsorship” model
(Terpsichore AB)
‐ Danie du Plessis, Senior Vice President, Medical
International, GSK (confirmed)
‐ Linda Sneddon, Compliance MPD EMEA, WL Gore &
Associates (confirmed)
‐ Anthony McQuillan, EMEAC Legal & Compliance, Vice
President, Medtronic (confirmed)
Moderator: tbc
Description: With industry planning to move out of direct
sponsorship across the world and more particularly in Europe, China
and Brazil, there are many challenges that need to be addressed in
order to ensure a smooth transition. Such challenges include e.g.
how to continue to support medical education, how to communicate
to customers, how to set up good processes for managing the
compliance risks existing with indirect sponsorship, etc. and will be
discussed in this session.
11.00 -11.30 Networking break
(Convention Level and the Erato Terrace)
11.30 -12.35 Parallel session 1: Local implementation of the EDMA/Eucomed
“Direct Sponsorship Phase-out” recommendation: Challenges for
national associations in Europe
(Thalia 1,2,3)
‐ Anna Lefevre Skjöldebrand, CEO, Swedish Medtech &
Chairwoman of the Eucomed National Associations
Network (confirmed)
‐ Gerry Livadas, General Secretary, SEIV (confirmed)
‐ Lorenzo Fracassi, Consigliere Delegato, Dasit Group
S.p.A. & Member of the EDMA Board (confirmed)
Moderator:
Description: The EDMA ExeCo and Eucomed Board recommendation
to phase out direct sponsorship by the end of 2017 has important
implications for, and raises many concerns from, the national
associations, whose membership is much broader than the
EDMA/Eucomed membership, including many SMEs. Moreover, the
economic circumstances in some of the countries create a situation
where HCPs need the financial support from industry in order to
receive the necessary continuing medical education. Such challenges
6. DRAFT AGENDA
6
19-21 May 2015
Athens Hilton
Athens, Greece
and how to overcome them will be discussed in this session.
11.30 -12.35 Parallel session 2: Indirect Sponsorship and new approaches to
third-parties: What are the options and what’s ahead? (Hesperides
Room)
Moderator: Robert McCully, Partner, Shook, Hardy and Bacon
(confirmed)
Description: This session will discuss how to organize the financial
support to third-parties and how to manage grants in order to avoid
new corruption risks and existing pitfalls.
11.30 -12.35 Parallel session 3: How to organize the communication to
customers? Communicating new support structures to HCPs
(Santorini)
‐ Rick Peterson, General Counsel, AAOS (confirmed)
Moderator: tbc
Description: The panel will be discussing the challenges and
exchange best practices how to communicate effectively, the
changes brought in compliance objectives.
11.30 -12.35 Parallel session 4: Best practices in distributors due diligence
(Thalia 4)
Moderators: Red Flag (invited)
Description:
12.35 -13.35 Networking Lunch
(Terpsichore D)
13.35 – 14.50 Plenary session: Moving to new models of support for medical
education: Considerations from physicians and scientific societies
(Terpsichore AB)
‐ Karen Hackett, CEO, AAOS (confirmed)
‐ Isabel Bardinet, CEO, ESC (confirmed)
Moderator: Skye Potesta, Medical Director, Advanced Surgical
Device Division, Smith & Nephew (invited)
Description: Discussion with scientific societies on how the changing
compliance landscape affects continuing medical education of
healthcare professionals (HCPs) and how to ensure that HCPs around
7. DRAFT AGENDA
7
19-21 May 2015
Athens Hilton
Athens, Greece
the world continue to have access to the education they need.
14.50 – 15.00 Closing remarks (Terpsichore AB)
Sinéad Keogh, Director, Irish Medical Devices Assosication (IMDA)
(confirmed)
15.00 Adjournment